drugset / Trial / NCT00247078
The Efficacy and Safety of Aracmyn in Patients With Systemic Latrodectism
Phase 2
Completed
24 enrolled
Instituto Bioclon S.A. de C.V.
Rocky Mountain Poison and Drug Center · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to compare the safety and effectiveness of an investigational antivenom and the current standard of care (pain management with opioid analgesics) for treating patients with a widow spider bite. The working hypotheses are as follows: 1. the investigational antivenom is more promptly effective at alleviating the pain associated with a widow spider bite than routine management with opioid pain medication 2. the investigational antivenom is as safe a treatment as opioid pain medication in treating patients with a widow spider bite.
Timeline
- Start
- 2005-10
- Primary completion
- 2006-10
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Analatro | Protein / enzyme biologic | 3 unknown | Intravenous |